Assays

Assays

VITROS syphilis assay now available on VITROS 3600 immunodiagnostic system, VITROS 5600 and VITROS XT 7600 integrated systems in the U.S.

LABline

Aug. 30, 2024

QuidelOrtho receives FDA 510(k) clearance for its VITROS syphilis assay.

Flexible Syndromic Solutions for Respiratory Diagnostics 

Aug. 30, 2024

Assays

Bio-Rad launches new Specialty Immunoassay Plus controls

LABline

Aug. 23, 2024

Assays

Thermo Fisher Scientific announces extended 510k Clearance of Freelite Assays for evaluation of MGUS, a precursor to multiple myeloma

LABline

July 30, 2024

Assays

Diasorin receives FDA de-Novo grant for the Simplexa C. auris Direct assay on the LIAISON MDX instrument

LABline

July 19, 2024

Assays

Siemens Healthineers offers new way to detect a broken heart: NT proBNPII assay now part of Atellica cardiac testing menu

LABline

June 28, 2024

Assays

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) — a key marker for hereditary cardiovascular risk

LABline

May 23, 2024

The test has been developed in collaboration with Amgen.

Assays

OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research

LABline

May 2, 2024

A single streamlined NGS process.

Assays

Roche granted FDA Breakthrough Device Designation for pTau217 blood test to support earlier Alzheimer's disease diagnosis

LABline

April 12, 2024

Roche and Lilly believe the test could play an important role in improving access to early and accurate Alzheimer’s diagnosis.

Assays

New reproductive assay from Siemens Healthineers provides critical information to guide in vitro fertilization decisions

LABline

March 14, 2024

The Anti-Müllerian Hormone Assay reveals a patient's ovarian reserve information.

Assays

Complications and diagnosis of pre-eclampsia

Jason Armstrong

Feb. 26, 2024

The placenta is an ephemeral organ that provides us with the nutrients necessary for development and our initial immunity, removes malevolent agents, and much more before being...

Assays

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

LABline

Jan. 8, 2024

NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S.

Assays

Product Focus - Assays

MLO Staff

Dec. 18, 2023

Extend the power of HPV testing BD Onclarity HPV Assay is an FDA-approved test with extended genotyping to individually identify high-risk HPV types beyond 16, 18 and 45, providing...